Booster Dose Side Effects Similar to Second Dose, Study Says
A new study published in CDC's Morbidity and Mortality Weekly Report (MMWR) reveals that booster doses of Covid-19 vaccines were well-tolerated.
-
2.21 million persons in the United States received booster doses of Covid-19 vaccination
Dr. Rochelle Walensky, CDC Director, said on Tuesday that new evidence showed that booster doses of Covid-19 vaccinations have been well-tolerated.
During a White House Covid-19 briefing, Walensky said, referring to a new study published in the CDC's Morbidity and Mortality Weekly Report, that “the frequency and type of side effects were similar to those seen after the second vaccine doses, and they were mostly mild or moderate and short-lived."
According to the current data, 2.21 million persons in the United States received booster doses of Covid-19 vaccination after their main shots.
Furthermore, the current analysis contains reports from August 12, when the FDA approved extra dosages for some immunocompromised persons, and from September 19, when the FDA approved additional doses for certain immunocompromised people.
No surprising patterns of adverse reactions were discovered, the report added.
The report stressed that "the third Covid-19 shots appear to be safe and people experienced similar mild to moderate reactions, if any, to the Covid-19 vaccine."
